FITY (Fifty 1 Labs) Net Income (Continuing Operations): $-0.00 Mil (TTM As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Fifty 1 Labs Net Income (Continuing Operations)?

Fifty 1 Labs FITY Net Income (Continuing Operations) is $-0.00 Mil as of Jun. 2024.

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Fifty 1 Labs's Net Income (Continuing Operations) for the six months ended in Jun. 2024 was $-0.00 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00 Mil.

Fifty 1 Labs  (OTCPK:FITY) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Fifty 1 Labs Net Income (Continuing Operations) Related Terms

Fifty 1 Labs Net Income (Continuing Operations) Historical Data

* Premium members only.

The historical data trend for Fifty 1 Labs's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fifty 1 Labs Net Income (Continuing Operations) Chart

Fifty 1 Labs Annual Data
Trend Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.89 0.00 0.02 -0.51 -0.00

Fifty 1 Labs Semi-Annual Data
Dec03 Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1.89 0.00 0.02 -0.51 -0.00

Fifty 1 Labs Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income (Continuing Operations) of $-0.00 Mil mean?
Fifty 1 Labs (FITY) has a Net Income (Continuing Operations) of $-0.00 Mil as of Jun. 2024. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Fifty 1 Labs and its competitors.
Is Fifty 1 Labs' Net Income (Continuing Operations) too high?
Fifty 1 Labs' current Net Income (Continuing Operations) is $-0.00 Mil.
How does Fifty 1 Labs' Net Income (Continuing Operations) compare to GRPS and KOAN?
Fifty 1 Labs' Net Income (Continuing Operations) of $-0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Drug Manufacturers company?
A good Net Income (Continuing Operations) depends on the Drug Manufacturers industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Fifty 1 Labs and its competitors. Fifty 1 Labs's current Net Income (Continuing Operations) is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fifty 1 Labs stock overvalued right now?
Fifty 1 Labs (FITY) has a current Net Income (Continuing Operations) of $-0.00 Mil. The current Net Income (Continuing Operations) is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Fifty 1 Labs (FITY), the current Net Income (Continuing Operations) is $-0.00 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fifty 1 Labs Business Description

Address 1505 West 2nd Avenue, Suite 506, Melbourne, FL, USA, V6J 1H2
Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.